Why Prime Medicine Stock Was Climbing Higher This Week
News of a fresh investigational program was putting some zip into the shares of gene-editing company Prime Medicine (NASDAQ: ...
Inhalable Biologics Industry Report 2025: World Market to Nearly Triple in Size by 2030, Reaching $10.06 Billion at a CAGR of 17.6%
The "Inhalable Biologics Market Size, Share & Trends Analysis Report by Biologics (Peptides & Proteins, Monoclonal Antibodies ...
mRNA Vaccines Market Trends and Competition Analysis 2025-2030: Revenues are Projected to Nearly Double, Growing by ~$8 Billion
The "mRNA Vaccines Market by Technology Type, Route of Administration, Manufacturing Process, Vaccine Classification, Application Areas, End-User, Distribution Channel - Global Forecast 2025-2030" ...
Technion close to develop oral consumption of medications to tackle COVID, flu, instead of vaccines
Imagine if antibodies, hormones for fertility, proteins like insulin, and vaccines could be swallowed instead of taken by ...
CNBCTV189d
What's the new Chinese vaccine that promises to prevent stroke, heart attacks? Explained
The cocktail design of vaccine, tried on mice by Chinese scientists, mitigates the progression of fatty plaque in arteries ...
Zacks Investment Research on MSN11d
BEAM Down Despite Positive Initial Data From Genetic Disorder Study
Beam Therapeutics Inc. BEAM announced positive initial safety and efficacy data from a phase I/II study, which is evaluating ...
Fierce Biotech11d
Daiichi taps Nosis to deliver RNA therapies beyond the liver
Daiichi Sankyo is stepping up its interest in RNA therapies, teaming with Nosis Biosciences to design drug candidates capable ...
Opinion: Covid’s deadliest effect took five years to appear
It has been five years since the world was blown into the tumult of a lethal pandemic. Back then, deserted streets and ...
Beam data ‘encouraging,’ support continuation of trial, says H.C. Wainwright
H.C. Wainwright analyst Patrick Trucchio reiterates a Buy rating and $80 price target on Beam Therapeutics (BEAM) shares after the company ...
The Fence Post12d
Nebraska-based global center to drive bioeconomy for the future of food
An international research project led by the University of Nebraska-Lincoln aims to transform the future of food by driving ...
Medindia16d
Everest Medicines Announces First Patient Dosed with EVM16, Its First Internally Developed Personalized mRNA Cancer Vaccine
The first patient has been dosed with EVM16 at Peking University Cancer Hospital, marking a major milestone as Everest's proprietary AI-based tumor neoantigen prediction algorithm ...